Molecular profile
Molecular profile
- Molecule class
- Cyclic peptide
- Origin
- Synthetic analogue
- Primary target system
- Melanocortinrezeptoren, insbesondere MC4R
- Development stage
- Authorised active substance
Zyklisches Heptapeptid und Melanocortinrezeptor-Agonist.
Mechanism and signalling
Mechanism and signalling
Central melanocortin-receptor activation affects neuroendocrine and motivational networks; contributions from individual receptor subtypes are complex.
Scientific classification
Scientific classification
This profile maps Bremelanotid to the research areas reproductive, neuro. Molecule class, evidence level, development stage and regulatory status are separated so that preclinical findings are not confused with authorised uses.
Peptide signals related to reproductive axes, social behaviour and sexual function.
Neuropeptides and analogues in models of neuronal signalling, stress and pain.
Evidence base
Approval and post-marketing data
Approval trials and prescribing information support the specific U.S. indication. They do not support unlicensed products or other uses.
Regulatory status
Specifically approved in the U.S.
The substance has a specific U.S. approval. This does not constitute general authorisation in Germany or the European Union, nor approval of unlicensed products.
Safety and use notice
No dosing or administration recommendation
The available evidence does not establish safe self-directed use. This profile intentionally provides no dosing, sourcing or administration guidance.
Sources and registries